Literature DB >> 16900393

Multifaceted role of Rho proteins in angiogenesis.

Sofia D Merajver1, Saad Z Usmani.   

Abstract

The Rho family of GTPases is part of the Ras superfamily. The Rho, Rac, and Cdc42 members of the family are present in mammalian cells and have been the subject of attention of researchers due to their vast spectrum of functions. Rac 1, Cdc42, and RhoA are well-known for their role in the regulation of the actin cytoskeleton in promoting the formation of lamellipodia, filopodia, and stress fibers, respectively. The Rho proteins also participate in the control of cell growth, motility, cell-cell adhesions, morphogenesis, cytoskeletal dynamics, and cellular trafficking. The mechanisms for eliciting these functions have become clearer during the last decade. Concordant with their roles in multiple processes of cellular control, the Rho proteins have been shown to be involved in tumor growth, progression, metastasis, and now angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16900393     DOI: 10.1007/s10911-006-9002-8

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  111 in total

1.  Lipid kinases are novel effectors of the GTPase Rac1.

Authors:  C L Carpenter; K F Tolias; A Van Vugt; J Hartwig
Journal:  Adv Enzyme Regul       Date:  1999

2.  Capillary morphogenesis during human endothelial cell invasion of three-dimensional collagen matrices.

Authors:  G E Davis; S M Black; K J Bayless
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-09       Impact factor: 2.416

3.  Rac/Cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin through phosphorylation at serine 16.

Authors:  H Daub; K Gevaert; J Vandekerckhove; A Sobel; A Hall
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

4.  Cross-linking of integrins induces tyrosine phosphorylation of the proto-oncogene product Vav and the protein tyrosine kinase Syk in human factor-dependent myeloid cells.

Authors:  A Gotoh; H Takahira; R L Geahlen; H E Broxmeyer
Journal:  Cell Growth Differ       Date:  1997-06

5.  Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity.

Authors:  C Muñoz; D Pascual-Salcedo; M C Castellanos; A Alfranca; J Aragonés; A Vara; J M Redondo; M O de Landázuri
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

6.  Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway.

Authors:  D Joyce; B Bouzahzah; M Fu; C Albanese; M D'Amico; J Steer; J U Klein; R J Lee; J E Segall; J K Westwick; C J Der; R G Pestell
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

7.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

8.  Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.

Authors:  A Takahashi; H Sasaki; S J Kim; K Tobisu; T Kakizoe; T Tsukamoto; Y Kumamoto; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

Review 9.  WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement.

Authors:  T Takenawa; H Miki
Journal:  J Cell Sci       Date:  2001-05       Impact factor: 5.285

10.  Integrin-mediated signals regulated by members of the rho family of GTPases.

Authors:  E A Clark; W G King; J S Brugge; M Symons; R O Hynes
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

View more
  30 in total

1.  Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation.

Authors:  Ke Xu; Diana C Chong; Scott A Rankin; Aaron M Zorn; Ondine Cleaver
Journal:  Dev Biol       Date:  2009-03-06       Impact factor: 3.582

Review 2.  Small Rho GTPases in the control of cell shape and mobility.

Authors:  Arun Murali; Krishnaraj Rajalingam
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

3.  PI3K, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells.

Authors:  Heather N Woodward; Adil Anwar; Suzette Riddle; Laimute Taraseviciene-Stewart; Miguel Fragoso; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

Review 4.  Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.

Authors:  Chryso Kanthou; Gillian M Tozer
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

5.  Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.

Authors:  Xiufeng Pang; Tingfang Yi; Zhengfang Yi; Sung Gook Cho; Weijing Qu; Decha Pinkaew; Ken Fujise; Mingyao Liu
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

6.  A novel regulator of angiogenesis in endothelial cells: 5-hydroxytriptamine 4 receptor.

Authors:  Jasmina Profirovic; Elena Strekalova; Norifumi Urao; Aleksandar Krbanjevic; Alexandra V Andreeva; Sudhahar Varadarajan; Tohru Fukai; René Hen; Masuko Ushio-Fukai; Tatyana A Voyno-Yasenetskaya
Journal:  Angiogenesis       Date:  2012-08-18       Impact factor: 9.596

7.  Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.

Authors:  Gabriela D'Amico; Stephen D Robinson; Mitchel Germain; Louise E Reynolds; Gareth J Thomas; George Elia; Garry Saunders; Marcus Fruttiger; Victor Tybulewicz; Georgia Mavria; Kairbaan M Hodivala-Dilke
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

8.  Cyclodepsipeptides from marine sponges: natural agents for drug research.

Authors:  Gowri Shankar Bagavananthem Andavan; Rosa Lemmens-Gruber
Journal:  Mar Drugs       Date:  2010-03-22       Impact factor: 5.118

9.  Rac and Rho GTPases in cancer cell motility control.

Authors:  Matteo Parri; Paola Chiarugi
Journal:  Cell Commun Signal       Date:  2010-09-07       Impact factor: 5.712

10.  Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.

Authors:  Brandy M Heckman-Stoddard; Tracy Vargo-Gogola; Peter R McHenry; Vivian Jiang; Matthew P Herrick; Susan G Hilsenbeck; Jeffrey Settleman; Jeffrey M Rosen
Journal:  Breast Cancer Res       Date:  2009-08-24       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.